Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03187730 · ClinicalTrials.gov registry record · Phase 4
Integrating Financial Management Counseling and Smoking Cessation Counseling to Reduce Health and Economic Disparities in Low-Income Immigrants
A Phase 4 study of Smoking Cessation, sponsored by NYU Langone Health.
- Completed
- Registry status
- Phase 4
- Development phase
- 410
- Enrollment target
- 1
- Study location
NCT03187730 is a Phase 4 study of Smoking Cessation that has completed, run by NYU Langone Health. The registered enrollment target is 410 participants, below the 473-participant average among 188 other Smoking Cessation trials with a reported enrollment target (13% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03187730, a Phase 4 study of Smoking Cessation, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 410 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a 24 month pilot project that will implement and evaluate an innovative program that integrates financial counseling with smoking cessation counseling for low-income immigrants.
Conditions Studied
Interventions
- DRUG Nicotine Replacement Therapy (NRT)
- BEHAVIORAL Integrated Smoking Cessation and Financial Counseling
- BEHAVIORAL Waitlist Integrated Smoking Cessation and Financial Counseling
Study Locations (1)
New York
- New York University School of Medicine - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 410 participants |
| Start Date | 2017-09-22 |
| Est. Completion | 2021-04-30 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03187730
The ClinicalTrials.gov registry entry for NCT03187730 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 410 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 473-participant average among 188 other Smoking Cessation trials with a reported enrollment target (13% lower). The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Smoking Cessation appearing as the primary indexed condition, and to 3 interventions - of which Nicotine Replacement Therapy (NRT) is the first listed.
NCT03187730 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT03187730 about?
NCT03187730 is a clinical study titled "Integrating Financial Management Counseling and Smoking Cessation Counseling to Reduce Health and Economic Disparities in Low-Income Immigrants". This is a 24 month pilot project that will implement and evaluate an innovative program that integrates financial counseling with smoking cessation counseling for low-income immigrants.
What is the current status of trial NCT03187730?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 410 participants. The study started on 2017-09-22. Estimated completion is 2021-04-30.
What conditions does trial NCT03187730 study?
This clinical trial studies the following conditions: Smoking Cessation.
What interventions are being tested in trial NCT03187730?
The interventions under investigation include: Nicotine Replacement Therapy (NRT) (DRUG), Integrated Smoking Cessation and Financial Counseling (BEHAVIORAL), Waitlist Integrated Smoking Cessation and Financial Counseling (BEHAVIORAL).
Who is sponsoring clinical trial NCT03187730?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03187730 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Smoking Cessation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Modifying Progesterone and Estradiol Levels to Prevent Postpartum Cigarette Smoking Relapse and Reduce Secondhand Smoke Exposure in Infants and Children
RECRUITING · Phase 4
-
The Options 2 Study
RECRUITING · Phase 4
-
Smoking Cessation Program in the Construction Sector
RECRUITING · Phase 4
-
The Avenues Study: Dual Use Cessation
RECRUITING · Phase 4
-
Using Multiphase Optimization Strategy (MOST) to Optimize a Cost-effective, Sustainable and Scalable Smoking Cessation Package for Smokers in HIV Clinical Care
RECRUITING · Phase 4
-
Implementing Tobacco Treatment in Low Dose CT Lung Cancer Screening Sites
ACTIVE NOT RECRUITING · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.